$VXRT The Dept of Defense and BARDA sure seem to be in a hurry of late to setup government contracts for clinical trial testing services with Vaxart’s clinical trial partner - Pharm-Olam (noted in Vaxart corporate decks from Sept). BARDA just signed a $250,000,000 deal with Pharm-Olam. Could these agencies be setting-up these services for Vaxart in preparation for a downstream Vaxart Covid vax phase 3 trial and for other pipeline trials? Could they be purchasing Pharm-Olam clinical trial services on behalf of Vaxart to keep Vaxart “low profile”? I don’t see any other COVID vax makers in phase 2 or 3 using Pharm-Olam now or in their other past trials... Sept 23: DoD Selects Pharm-Olam to Support to Operation Warp Speed Vax Trials To support Phase III clinical trials of one or more lead COVID-19 vaccine candidates being developed under Operation Warp Speed. contractpharma.com/contents... Oct 9: BARDA taps Pharm-Olam to join its trial network as it boosts CRO contracts fiercebiotech.com/cro/as-ba...
  • 14
14 Likes